Baylisascaris procyonis is a roundworm that does not affect its definitive host, raccoons (Procyon lotor), but may have a devastating effect when ingested by paratenic hosts such as Allegheny woodrats (Neotoma magister). Despite being considered a major factor in woodrat population extirpation and decline in states northward, there have been no large-scale surveys for raccoon roundworm in Virginia, US. From 2022 to 2024, we visited 60 karst or nonkarst rocky habitats known (current or historical) or suspected to be Allegheny woodrat locations in western Virginia.
View Article and Find Full Text PDFObjective: This study was designed to assess physician experiences with utilization management and burnout and investigate whether they are linked.
Study Design: We conducted an electronic survey with items related to demographics, profession, utilization management, burnout, and potential policy solutions.
Methods: The survey was sent to 7222 physicians working in outpatient settings who were recruited from a large, opt-in database.
Introduction: Understanding genetic contributors to sarcopenia (age-related loss of muscle strength and mass) is key to finding effective therapies. Variants of the bradykinin receptor 2 (BDKRB2) have been linked to athletic and muscle performance. The rs1799722-9 and rs5810761 T alleles have been shown to be overrepresented in endurance athletes, possibly due to increased transcriptional rates of the receptor.
View Article and Find Full Text PDFBackground: Allopurinol is a xanthine oxidase inhibitor that lowers serum uric acid and is used to prevent acute gout flares in patients with gout. Observational and small interventional studies have suggested beneficial cardiovascular effects of allopurinol.
Objective: To determine whether allopurinol improves major cardiovascular outcomes in patients with ischaemic heart disease.
Blood Pressure Variability (BPV) is associated with cardiovascular risk and serum uric acid level. We investigated whether BPV was lowered by allopurinol and whether it was related to neuroimaging markers of cerebral small vessel disease (CSVD) and cognition. We used data from a randomised, double-blind, placebo-controlled trial of two years allopurinol treatment after recent ischemic stroke or transient ischemic attack.
View Article and Find Full Text PDF